Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 279, Issue 1 48-1, 2000, Pages

  Hamanaka, Ichiro ^a   Saito, Yoshihiko ^a   Nishikimi, Toshio ^b   Magaribuchi, Tatsuo ^a   Kamitani, Shigeki ^a   Kuwahara, Koichiro ^a   Ishikawa, Masahiro ^a   Miyamoto, Yoshihiro ^a   Harada, Masaki ^a   Ogawa, Emiko ^a   Kajiyama, Noboru ^a   Takahashi, Nobuki ^a   Izumi, Takehiko ^a   Shirakami, Gotaro ^a   Mori, Kenjiro ^a   Inobe, Yoshito ^a   Kishimoto, Ichiro ^a   Masuda, Izuru ^a   Fukuda, Kazuhiko ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Blood pressure; Natriuretic peptide; Nitric oxide synthase

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARDIOTROPHIN 1; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HEART HEMODYNAMICS; HEART OUTPUT; HEART RATE; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0033868722     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.279.1.h388     Document Type: Article

References (42)

1. Leptin enters the brain by a saturable system independent of insulin
2. Role of cytokines in heart failure
3. Plateletderived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta
4. OB protein binds specifically to the choroid plexus of mice and rats
5. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
6. Cardiotrophin-1 (CT-1), a new agonist for a gp130 signaling pathway, stimulates brain natriuretic peptide(BNP) secretion more abundantly than endothelin-1 (ET-1)
7. cDNA cloning of rat cardiotrophin-1 (CT-1): Augmented expression of CT-1 gene in ventricle of genetically hypertensive rats
8. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload
9. Effects of cardiotrophin-1 on haemodynamics and cardiac function in conscious rats
10. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide
11. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro
12. Endothelin-1 and cardiotrophin-1 induce brain natriuretic peptide gene expression by distinct transcriptional mechanisms
13. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
14. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock
15. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1
16. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure
17. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
18. Cardiovascular and renal effects of adrenomedullin in rat with heart failure
19. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload
20. Overlapping and distinct signals through leptin receptor (OB-R) and a closely related cytokine signal transducer, gp130
21. Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats
22. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex
23. Interleukin I induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
24. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy
25. Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog
26. 2+-dependent signaling
27. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
28. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system
29. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumor necrosis factor-alpha
30. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
31. Low doses of endothelin-1 inhibit atrial natriuretic peptide secretion
32. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response
33. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits
34. An immunoluminometric assay for cardiotrophin-1: A newly identified cytokine is present in normal human plasma and is increased in heart failure
35. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
36. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
37. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD)
38. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
39. Direct demonstration of insulin-like growth factor-induced nitric oxide production by endothelial cells
40. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
41. Cardiotrophin-1 activates a distinct form ofcardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways
42. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders